Catalent Adds Potent Drug Capabilities In Schorndorf, Germany Facility

Catalent Adds Potent Drug Capabilities in Schorndorf, Germany Facility

Date: 02/01/2010

Schorndorf, GERMANY, February 1, 2010 — Catalent Pharma Solutions, a leading provider of outsourced dose form manufacturing and packaging to the global pharmaceutical industry, has expanded its capabilities in its Schorndorf, Germany site to include a new potent products area. This important new capability enables Catalent to provide customers with complex and innovative dose form production, overencapsulation, and packaging solutions for potent products at its Schorndorf site.

For nearly 50 years, Catalent’s Schorndorf operation has provided a broad range of services to global, regional and local pharmaceutical customers. Today, Catalent provides oral dose form development, manufacturing and packaging services, as well as comprehensive supply chain solutions. In the fall of 2009, Catalent’s Schorndorf facility successfully completed an FDA inspection adding to a long track record of regulatory compliance, including German and other EU and international regulatory authorities.

 “We believe the addition of this new potent handling and over-encapsulation area will help to meet the needs of our customers, both global and local. I am also pleased that this investment was made here in Schorndorf, as it builds upon our team’s commitment to operational excellence, our regulatory track record, and our consistent focus on meeting our customers’ needs,” said Eric Schmidhaeuser, Managing Director of the Schorndorf operation.

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,400 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit .

more products. better treatments. reliably supplied.™